Relmada Therapeutics Inc. Common Stock is a biopharmaceutical company that focuses on the development of innovative therapies for central nervous system disorders. With a mission to improve the lives of patients suffering from pain, the company utilizes cutting-edge research and development to address unmet medical needs, making them a promising player in the healthcare industry.
